EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients
입원한 SARS-CoV-2 감염 환자의 결과 예측을 위한 EASIX
Immunology
[키워드] 95%CI
Activation
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus-2
Admission
age
allocation
Allogeneic
angiopoietin
angiopoietin-2 (Ang-2)
Biomarkers
caused
Cell
Cohort
Comorbidities
Comorbidity
Complication
coronavirus disease
Coronavirus disease 2019
Coronavirus-2
correlated
Course
COVID-19
COVID19
CXCL8
CXCL9
death
disease
dysfunction
EASIX
endothelial
endothelial activation and stress index
Endothelial cell
Endpoint
enrolled
Gender
hazard ratio
health-care system
help
Hospital admission
hospitalized patient
hospitalized patients
independent
Intensive
interferon-alpha
interleukin
Interleukin-18
life-threatening
mechanical ventilation
multivariable analysis
Odds ratio
outcome
pandemic
pathophysiology
Patient
patients treated
patients with COVID-19
predict
prediction
prediction of outcome
primary endpoint
resources
respiratory
Result
retained
SARS-CoV-2
SARS-CoV2 (COVID- 19)
Severe acute respiratory syndrome
severe acute respiratory syndrome Coronavirus
soluble thrombomodulin
stem cell
Stem cell transplantation
Stress
suppressor of tumorigenicity 2 (ST2)
Surveillance
survival
the disease
thrombomodulin
were assessed
[DOI] 10.3389/fimmu.2021.634416 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2021.634416 PMC 바로가기 [Article Type] Immunology